These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 2852028

  • 1. High dose BCNU chemotherapy with autologous bone marrow transplantation and full dose radiotherapy for grade IV astrocytoma.
    Mbidde EK, Selby PJ, Perren TJ, Dearnaley DP, Whitton A, Ashley S, Workman P, Bloom HJ, McElwain TJ.
    Br J Cancer; 1988 Dec; 58(6):779-82. PubMed ID: 2852028
    [Abstract] [Full Text] [Related]

  • 2. Prolongation of survival for high-grade malignant gliomas with adjuvant high-dose BCNU and autologous bone marrow transplantation.
    Johnson DB, Thompson JM, Corwin JA, Mosley KR, Smith MT, de los Reyes RA, Daly MB, Petty AM, Lamaster D, Pierson WP.
    J Clin Oncol; 1987 May; 5(5):783-9. PubMed ID: 3553437
    [Abstract] [Full Text] [Related]

  • 3. High-dose BCNU with autologous bone marrow rescue for recurrent glioblastoma multiforme.
    Hochberg FH, Parker LM, Takvorian T, Canellos GP, Zervas NT.
    J Neurosurg; 1981 Apr; 54(4):455-60. PubMed ID: 6259300
    [Abstract] [Full Text] [Related]

  • 4. Intensive 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) monochemotherapy and autologous marrow transplantation for malignant glioma.
    Phillips GL, Wolff SN, Fay JW, Herzig RH, Lazarus HM, Schold C, Herzig GP.
    J Clin Oncol; 1986 May; 4(5):639-45. PubMed ID: 3009725
    [Abstract] [Full Text] [Related]

  • 5. High-dose carmustine with autologous bone marrow transplantation for the adjuvant treatment of high-grade gliomas of the central nervous system.
    Wolff SN, Phillips GL, Herzig GP.
    Cancer Treat Rep; 1987 Feb; 71(2):183-5. PubMed ID: 3026626
    [Abstract] [Full Text] [Related]

  • 6. High-dose BCNU and autologous progenitor cell transplantation given with intra-arterial cisplatinum and simultaneous radiotherapy in the treatment of high-grade gliomas: benefit for selected patients.
    Fernández-Hidalgo OA, Vanaclocha V, Vieitez JM, Aristu JJ, Rebollo J, Gúrpide A, Aramendía JM, Moreno-Palanques R, Martín-Algarra S, Subirá ML, Brugarolas A.
    Bone Marrow Transplant; 1996 Jul; 18(1):143-9. PubMed ID: 8832007
    [Abstract] [Full Text] [Related]

  • 7. High dose BCNU with autologous bone marrow rescue in the treatment of recurrent malignant gliomas.
    Mortimer JE, Hewlett JS, Bay J, Livingston RB.
    J Neurooncol; 1983 Jul; 1(3):269-73. PubMed ID: 6088718
    [Abstract] [Full Text] [Related]

  • 8. High-dose BCNU followed by autologous hematopoietic stem cell transplantation in supratentorial high-grade malignant gliomas: a retrospective analysis of 114 patients.
    Durando X, Lemaire JJ, Tortochaux J, Van-Praagh I, Kwiatkowski F, Vincent C, Bailly C, Verrelle P, Irthum B, Chazal J, Bay JO.
    Bone Marrow Transplant; 2003 Apr; 31(7):559-64. PubMed ID: 12692621
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Sequential and adjuvant chemotherapy for malignant astrocytoma of the brain.
    Kessinger A, Lemon HM, Foley JF.
    J Surg Oncol; 1978 Apr; 10(6):543-7. PubMed ID: 215846
    [Abstract] [Full Text] [Related]

  • 15. The chemotherapy of brain tumors. Clinical experience with carmustine (BCNU) and vincristine.
    Fewer D, Wilson CB, Boldrey EB, Enot KJ, Powell MR.
    JAMA; 1972 Oct 30; 222(5):549-52. PubMed ID: 4343318
    [No Abstract] [Full Text] [Related]

  • 16. Phase 1 study of 28-day, low-dose temozolomide and BCNU in the treatment of malignant gliomas after radiation therapy.
    Raizer JJ, Malkin MG, Kleber M, Abrey LE.
    Neuro Oncol; 2004 Jul 30; 6(3):247-52. PubMed ID: 15279717
    [Abstract] [Full Text] [Related]

  • 17. Autologous bone-marrow transplantation: host effects of high-dose BCNU.
    Takvorian T, Parker LM, Hochberg FH, Canellos GP.
    J Clin Oncol; 1983 Oct 30; 1(10):610-20. PubMed ID: 6366127
    [Abstract] [Full Text] [Related]

  • 18. MGMT promoter methylation status and prognosis of patients with primary or recurrent glioblastoma treated with carmustine wafers.
    Gutenberg A, Bock HC, Brück W, Doerner L, Mehdorn HM, Roggendorf W, Westphal M, Felsberg J, Reifenberger G, Giese A.
    Br J Neurosurg; 2013 Dec 30; 27(6):772-8. PubMed ID: 23662801
    [Abstract] [Full Text] [Related]

  • 19. High-dose BCNU with ABMT followed by radiation therapy in the treatment of supratentorial glioblastoma multiforme.
    Linassier C, Benboubker L, Velut S, Calais G, Saudeau D, Jan M, Autret A, Berger C, Biron P, Colombat P.
    Bone Marrow Transplant; 1996 Sep 30; 18 Suppl 1():S69-72. PubMed ID: 8899180
    [No Abstract] [Full Text] [Related]

  • 20. Nursing management of the patient receiving high-dose BCNU with autologous bone marrow harvest.
    Gamel-Bentzel C.
    J Neurosurg Nurs; 1982 Apr 30; 14(2):98-102. PubMed ID: 6288899
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.